{"id":"f69d6ce5-386f-4e20-a18b-8bbfc7ccd9c9","url":"content/f69d6ce5-386f-4e20-a18b-8bbfc7ccd9c9","title":"Trastuzumab emtansine","outline":"/publication/75bfaa02-cc71-4a79-a7dd-dbc47541edea/outline","content":{"mime":"application/xml","data":"<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<!-- content-type_s: --><!-- Generated by cjs2htmlbase.xsl--><div data-ot-plugin=\"com.congility.html\" lang=\"en\" role=\"main\" xmlns:astX=\"http://www.astoriasoftware.com/translation\"><div class=\"topic recommendation commentable-section\" data-annot-id=\"topic.dita_45e1442e-32f5-4234-9c88-55d65084695f\" id=\"topic.dita_45e1442e-32f5-4234-9c88-55d65084695f\"><article aria-labelledby=\"ariaid-title1\" role=\"article\">\n  \n  \n  <div class=\"body recommendation-text\">\n    <p class=\"p\">People with HER2-positive early breast cancer can have <span class=\"ph medicine\" id=\"topic.dita_45e1442e-32f5-4234-9c88-55d65084695f___289840724\">trastuzumab emtansine</span> if: </p>\n    <div class=\"p\">\n      <ul class=\"ul commentable-section\" data-annot-id=\"topic.dita_45e1442e-32f5-4234-9c88-55d65084695f__ul_1\" id=\"topic.dita_45e1442e-32f5-4234-9c88-55d65084695f__ul_1\">\n        <li class=\"li\">\n          <p class=\"p\">they have had neoadjuvant taxane-based and HER2-targeted therapy and </p>\n        </li>\n        <li class=\"li\">\n          <p class=\"p\">residual invasive disease in the breast or lymph nodes is found during surgery. </p>\n        </li>\n      </ul>\n    </div>\n  </div>\n  <nav class=\"related-links\" role=\"navigation\"><div class=\"linklist\"><strong>Other products</strong><br/><ul class=\"linklist\"><li class=\"sublinklist\"><div class=\"linklist sublinklist\"><strong>Technology Appraisals</strong><br/><ul class=\"linklist\"><li class=\"linklist\"><a class=\"link\" href=\"https://www.nice.org.uk/guidance/ta632\" target=\"_blank\">Technology Appraisal Trastuzumab emtansine (TA632)</a></li></ul></div></li><li class=\"sublinklist\"><div class=\"linklist sublinklist\"><strong>British National Formulary</strong><br/><ul class=\"linklist\"><li class=\"linklist\"><a class=\"link\" href=\"https://bnf.nice.org.uk/drugs/trastuzumab-emtansine/\" target=\"_blank\">BNF Trastuzumab emtansine</a></li></ul></div></li></ul></div></nav>\n</article></div></div>"},"metadata":{},"solr":{"custom":{},"doc":{"href_s":"SD00835129","url_s":"content/f69d6ce5-386f-4e20-a18b-8bbfc7ccd9c9","title_s":"Trastuzumab emtansine","nextTopic_s":"0dc91755-beac-40b3-9941-df0105574863","prevTopic_s":"b9a2ce79-28eb-433d-85a6-aadb7735a21a"},"nice":{"nice_infotype_s":"recommendation","nice_guideline-id_s":"","nice_content-id_s":"","nice_content-type_s":"","nice_condition-disease_s":"BreastCancer","nice_recommendation-strength_s":"strong","nice_change-in-practice_s":"no"}},"contentObject":{"publicationuuid":"75bfaa02-cc71-4a79-a7dd-dbc47541edea","contentuuid":"f69d6ce5-386f-4e20-a18b-8bbfc7ccd9c9","contentjoinuuid":"6b259240-602e-4ec1-ac6f-2ae442bd7c35","contentjoinuuids":["6b259240-602e-4ec1-ac6f-2ae442bd7c35","b6411394-b182-48a0-932b-feab3de553ac"],"publicationjoinuuid":"356cbf6a-a380-418a-9856-781ae39f6dca"}}